Xencor reported $9.09M in EBIT for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebit Change
Alexion Pharmaceuticals ALXN:US $ 816.7M 185.9M
Alnylam Pharmaceuticals ALNY:US $ -146160000 40.09M
Amgen AMGN:US $ 2333M 204M
Arrowhead Research ARWR:US $ -31868000 3.64M
AstraZeneca AZN:LN 1.4B 366M
Biogen BIIB:US $ 858.6M 171.5M
Bristol Myers Squibb BMY:US $ 2967M 411M
Cytokinetics CYTK:US $ -54797000 14.19M
Epizyme EPZM:US $ -58231000 6.11M
GlaxoSmithKline GSK:LN 1.96B 281M
Johnson & Johnson JNJ:US $ 7033M 2723M
Karyopharm Therapeutics KPTI:US $ -49048000 3.32M
Macrogenics MGNX:US $ -40279000 11.01M
Merk MRK:US $ 3930M 332M
Novartis NOVN:VX 3.4B 415M
Pfizer PFE:US $ 6662M 905M
Regeneron Pharmaceuticals REGN:US $ 3347.2M 2234.5M
Seattle Genetics SGEN:US $ -89603000 32.82M
Xencor XNCR:US $ 9.09M 24.76M